Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130(Cas)

Cancer Research

Volumn 59, Issue 2, 1999, Pages 442-449

  Tamura, Masahito ^a   Gu, Jianguo ^a   Takino, Takahisa ^a   Yamada, Kenneth M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; FOCAL ADHESION KINASE; PHOSPHATASE;

ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CELL ADHESION MOLECULES; CELL DIVISION; CELL MOVEMENT; CRK-ASSOCIATED SUBSTRATE PROTEIN; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEINS; PTEN PHOSPHOHYDROLASE; RETINOBLASTOMA-LIKE PROTEIN P130; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033556443     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tyoko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
2. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavtigian, S. V. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
3. Li, D. M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57: 2124-2129, 1997.
4. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S., and Sidransky, D. Frequent inactivation of PTEN/ MMAC1 in primary prostate cancer. Cancer Res., 57: 4997-5000, 1997.
5. Gronbaek, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E., and Hou-Jensen, K. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood, 91: 4388-4390, 1998.
6. Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent evert in malignant melanoma. Cancer Res., 57: 3660-3663, 1997.
7. Rhei, E., Kang, L., Bogomolniy, F., Federici, M. G., Borgen, P. I., and Boye, J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res., 57: 3657-3659, 1997.
8. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
9. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R., and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57: 3935-3940, 1997.
10. Teng, D. H-F., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., Ellis, L., El-Naggar, A., Frazier, M., Jasser S., Langford, L. A., Lee, J., Mills, G. B., Pershouse, M. A., Pollack, R. E., Tornos, C., Troncoso, P., Yung, W. K. A., Fujii, G., Berson, A., Bookstein, R., Bolen, J. B., Tavtigian, S. V., and Steck, P. A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57: 5221-5225, 1997.
11. Wang, S. I., Pue, J., Li, J., Bruce, J. N., Cairns, P., Sidransky, D., and Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res., 57: 4183-4186, 1997.
12. Olschwang, S., Serova-Sinilnikova, O. M., Lenoir, G. M., and Thomas, G. PTEN germ-line mutations in juvenile polyposis coli. Nat. Genet., 18: 12-14, 1998.
13. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L., Wang, S. L. Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
14. Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
15. Fumari, F. B., Lin, H., Huang, H. S., and Cavenee, W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA, 94: 12479-12484, 1997.
16. Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J., Morimoto, A., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., and Bookstein, R. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res., 58: 2331-2334, 1998.
17. Myers, M. P., Stolarov, J. P., Eng, C. Li, J., Wang, S. I., Wigler, M. H., Parsons, R., and Tonks, N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94: 9052-9057, 1997.
18. Li, L., Ernsting, B. R., Wishart, M. J., Lohse, D. L., and Dixon, J. E. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J. Biol. Chem., 272: 29403-29406, 1997.
19. Rasheed, B. K., Stenzel, T. T., McLendon, R. E., Parsons, R., Friedman, A. H., Friedman, H. S., Bigner, D. D., and Bigner, S. H. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res., 57: 4187-4190, 1997.
20. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., and Bova, G. S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res., 58: 204-209, 1998.
21. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (Washington DC), 280: 1614-1617, 1998.
22. Hanks, S. K., and Polte, T. R. Signaling through focal adhesion kinase. Bioessays, 19: 137-145, 1997.
23. Schlaepfer, D. D., and Hunter, T. Integrin signaling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol., 8: 151-157, 1998.
24. Guan, J. L. Focal adhesion kinase in integrin signaling. Matrix Biol., 16: 195-200, 1997.
25. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science (Washington DC), 268: 233-239, 1995.
26. Ilic, D., Damsky, C., and Yamamoto, T. Focal adhesion kinase: at the crossroads of signal transduction. J. Cell Sci., 110: 401-407, 1997.
27. Yamada, K. M., and Geiger, B. Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol., 9: 76-85, 1997.
28. Sehlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.), 372: 786-791, 1994.
29. scr. Mol. Cell. Biol., 14: 1680-1688, 1994.
30. Schlaepfer, D. D., and Hunter, T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem., 272: 13189-13195, 1997.
31. Sehlaepfer, D. D., Jones, K. C., and Hunter, T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src-and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol. Cell. Biol., 18: 2571-2585, 1998.
32. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol., 140: 211-221, 1998.
33. Tachibana, K., Urano, T., Fujita, H., Ohashi, Y., Kamiguchi, K., Iwata, S., Hirai, H., and Morimoto, C. Tyrosine phosphorylation of Crk-associated substrates by focal adhesion kinase. A putative mechanism for the integrin-mediated tyrosine phosphorylation of Crk-associated substrates. J. Biol. Chem., 272: 29083-29090, 1997.
34. Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J. Biol. Chem., 271: 13649-13655, 1996.
35. Cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell Biol., 16: 2606-2613, 1996.
36. Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., and Cheresh, D. A. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J. Cell Biol., 140: 961-972, 1998.
37. Cas to focal adhesions. Mol. Cell. Biol., 17: 3884-3897, 1997.
38. Lacalle, R. A., Pulido, D., Vara, J., Zalacain, M., and Jimenez, A. Molecular analysis of the pac gene encoding a puromycin N-acetyl transferase from Streptomyces alboniger. Gene (Amst.), 79: 375-380, 1989.
39. LaFlamme, S. E., Thomas, L. A., Yamada, S. S., and Yamada, K. M. Single subunit chimeric integrins as mimics and inhibitors of endogenous inlegrin functions in receptor localization, cell spreading and migration, and matrix assembly. J. Cell Biol., 126: 1287-1298, 1994.
40. 5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin. J. Biol. Chem., 271: 11016-11022, 1996.
41. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182: 1545-1556, 1995.
42. Flint, A. J., Tiganis, T., Barford, D., and Tonks, N. K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA, 94: 1680-1685, 1997.
43. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sohue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (Lond.), 377: 539-544, 1995.
44. Cary, L. A., Chang, J. F., and Guan, J-L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci., 109: 1787-1794, 1996.
45. Frisch, S. M., Vuori, K., Ruoslahti, E., and Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol., 134: 793-799, 1996.
46. FAK in cultured fibroblasts results in apoptosis. J. Cell Biol., 135: 1383-1390, 1996.
47. Maehama, T., and Dixon, J. E. The tumor suppressor. PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
48. Stamholic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., and Mak, T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95: 29-39, 1998.
49. Gu, J., Tamura, M., and Yamada, K. M. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated MAP kinase signaling pathways. J. Cell Biol., 143: 1375-1383, 1998.
50. FAK. Nature (Lond.), 380: 538-540, 1996.
51. Gates, R. E., King, L. E., Jr., Hanks, S. K., and Nanney, L. B. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ., 5: 891-899, 1994.
52. Romer, L. H., McLean, N., Turner, C. E., and Burridge, K. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol. Biol. Cell, 5: 349-361, 1994.
53. Gilmore, A. P., and Romer, L. H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell, 7: 1209-1224, 1996.
54. Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs. J. Biol. Chem., 270: 15398-15402, 1995.
55. Cas. Proc. Natl. Acad. Sci. USA, 92: 10678-10682, 1995.
56. Tremblay, L., Hauck, W., Nguyen, L. T., Allard, P., Landry, F., Chapdelaine, A., and Chevalier, S. Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. Mol. Endocrinol., 10: 1010-1020, 1996.
57. Weiner, T. M., Liu, E. T., Craven, R. J., and Cance, W. G. Expression of focal adhesion kinase gene and invasive cancer. Lancet, 342: 1024-1025, 1993.
58. FAK) in invasive human tumors. Cancer Res., 55: 2752-2755, 1995.
59. Chen, H. C., and Guan, J. L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA, 91: 10148-10152, 1994.
60. Wary, K. K. Mainiero, F., Isakoff, S. J., Marcantonio, E. E., and Giancotti, F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell, 87: 733-743, 1996.
61. Lin, T. H., Aplin, A. E., Shen, Y., Chen, Q., Schaller, M., Romer, L., Aukhil, I., and Juliano, R. L. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol., 136: 1385-1395, 1997.
62. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., and Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16: 2783-2793. 1997.
63. King, W. G., Mattaliano, M. D., Chan, T. O., Tsichlis, P. N., and Brugge, J. S. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/ mitogen-activated protein kinase pathway activation. Mol. Cell. Biol., 17: 4406-4418, 1997.
64. Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol., 10: 262-267, 1998.
65. Ruoslahti, E., and Reed, J. C. Anchorage dependence, integrins, and apoptosis. Cell, 77: 477-478, 1994.
66. Schwartz, M. A. Integrins, oncogenes, and anchorage independence. J. Cell Biol., 139: 575-578, 1997.
67. Meredith, J. E., and Schwartz, M. A. Integrins, adhesion and apoptosis. Trends Cell Biol., 7: 146-150, 1997.
68. Frisch, S. M., and Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol., 9: 701-706, 1997.
69. Xu, L. H., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ., 7: 413-418, 1996.
70. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. Pten is essential for embryonic development and tumor suppression. Nat. Genet., 19: 348-355, 1998.
71. Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., and Stark, G. R. The p53 network. J. Biol. Chem., 273: 1-4, 1998.